p53 Promotes Cardiac Dysfunction in Diabetic Mellitus Caused by Excessive Mitochondrial Respiration-Mediated Reactive Oxygen Species Generation and Lipid Accumulation

• DOI: 10.1161/circheartfailure.111.961565
• Publication Date: 2011-11-10T06:30:44Z
• Authors: Hideo Nakamura; Satoaki Matoba; Eri Iwai-Kanai; Masaki Kimata; Atsushi Hoshino; Mikihiko Nakaoka; Maki Katamura; Yoshifumi Okawa; Makoto Ariyoshi; Yuichiro Mita; Koji Ikeda; Mitsuhiko Okigaki; Souichi Adachi; Hideo Tanaka; Tetsuro Takamatsu; Hiroaki Matsubara
• Keywords: CD36 Antigens; Male; Mice, Knockout; 0301 basic medicine; 0303 health sciences; Diabetic Cardiomyopathies; Fatty Acids; Lipid Metabolism; Mice, Mutant Strains; Mitochondria, Heart; Streptozocin; Diabetes Mellitus, Experimental; 3. Good health; Diabetes Complications; Electron Transport Complex IV; Mice, Inbred C57BL; Disease Models, Animal; Mice; 03 medical and health sciences; Oxygen Consumption; Animals; Myocytes, Cardiac; Reactive Oxygen Species; Molecular Chaperones

Background— Diabetic cardiomyopathy is characterized by energetic dysregulation caused by glucotoxicity, lipotoxicity, and mitochondrial alterations. p53 and its downstream mitochondrial assembly protein, synthesis of cytochrome c oxidase 2 (SCO2), are important regulators of mitochondrial respiration, whereas the involvement in diabetic cardiomyopathy remains to be determined.

Methods and Results—

The role of p53 and SCO2 in energy metabolism was examined in both type I (streptozotocin [STZ] administration) and type II diabetic ( db/db ) mice. Cardiac expressions of p53 and SCO2 in 4-week STZ diabetic mice were upregulated (185% and 152% versus controls, respectively, P <0.01), with a marked decrease in cardiac performance. Mitochondrial oxygen consumption was increased (136% versus control, P <0.01) in parallel with augmentation of mitochondrial cytochrome c oxidase (complex IV) activity. Reactive oxygen species (ROS)-damaged myocytes and lipid accumulation were increased in association with membrane-localization of fatty acid translocase protein FAT/CD36. Antioxidant tempol reduced the increased expressions of p53 and SCO2 in STZ-diabetic hearts and normalized alterations in mitochondrial oxygen consumption, lipid accumulation, and cardiac dysfunction. Similar results were observed in db/db mice, whereas in p53-deficient or SCO2-deficient diabetic mice, the cardiac and metabolic abnormalities were prevented. Overexpression of SCO2 in cardiac myocytes increased mitochondrial ROS and fatty acid accumulation, whereas knockdown of SCO2 ameliorated them.

Conclusions— Myocardial p53/SCO2 signal is activated by diabetes-mediated ROS generation to increase mitochondrial oxygen consumption, resulting in excessive generation of mitochondria-derived ROS and lipid accumulation in association with cardiac dysfunction.